Becton Dickinson Infusion Therapy Systems, Inc.

Becton Dickinson Infusion Therapy Systems, Inc. — FDA 510(k) Submissions

Becton Dickinson Infusion Therapy Systems, Inc. has submitted 35 FDA 510(k) premarket notifications since 1997, of which 35 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days, Set, Administration, Intravascular, Tubes, Vials, Systems, Serum Separators, Blood Collection, Introducer, Catheter, Fab, Rhodamine, Antigen, Antiserum, Control . Use the specialty filter in the sidebar to narrow results.